Prostaglandin I2 plays a key role in zymosan-induced mouse pleurisy

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 2, 2008, Pages 601-609

  Yuhki, Koh Ichi ^a   Ushikubi, Fumitaka ^a   Naraba, Hiroaki ^b   Ueno, Akinori ^c   Kato, Hirotsugu ^d   Kojima, Fumiaki ^d   Narumiya, Shuh ^e   Sugimoto, Yukihiko ^e   Matsushita, Misao ^f   Oh ishi, Sachiko ^g  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f TOKAI UNIVERSITY   (Japan)

^g KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; COBROTOXIN; COMPLEMENT COMPONENT C3; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; INDOMETACIN; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTANOID RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; ZYMOSAN; 1 ((4 METHYLSULFONYL)PHENYL) 3 TRIFLUOROMETHYL 5 (4 FLUOROPHENYL)PYRAZOLE; 1-((4-METHYLSULFONYL)PHENYL)-3-TRIFLUOROMETHYL-5-(4-FLUOROPHENYL)PYRAZOLE; CYCLOOXYGENASE 2 INHIBITOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR; PYRAZOLE DERIVATIVE; SNAKE VENOM; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG INHIBITION; INNATE IMMUNITY; MOUSE; NONHUMAN; PLEURA CAVITY; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; GENETICS; MALE; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COBRA VENOMS; COMPLEMENT C3; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; EPOPROSTENOL; INDOMETHACIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PLEURISY; PYRAZOLES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PROSTAGLANDIN; ZYMOSAN;

EID: 42449164736     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.134494     Document Type: Article

References (40)

1. Brown GD and Gordon S (2001) A new receptor for β-glucans. Nature 413:36-37.
2. 4 hydrolase-deficient mice. J Immunol 163:6810-6819.
3. Cochrane CG, Muller-Eberhard HJ, and Aikin BS (1970) Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol 105:55-69.
4. Cooper JD, McDonald JW, Ali M, Menkes E, Masterson J, and Klement P (1980) Prostaglandin production associated with the pulmonary vascular response to complement activation. Surgery 88:215-221.
5. Dozen M, Yamaki K, and Oh-ishi S (1989) Captopril uncovers kinin-dependent release of arachidonic acid metabolites in carrageenin-induced rat pleurisy. Jpn J Pharmacol 51:101-105.
6. Fujita T, Matsushita M, and Endo Y (2004) The lectin-complement pathway-its role in innate immunity and evolution. Immunol Rev 198:185-202.
7. Gordon S (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927-930.
8. Guo R-F and Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23:821-852.
9. Harada Y, Tanaka K, Uchida Y, Ueno A, Oh-ishi S, Yamashita K, Ishibashi M, Miyazaki H, and Katori M (1982) Changes in the levels of prostaglandins and thromboxane and their roles in the accumulation of exudates in rat carrageenin-induced pleurisy-a profile analysis using gas chromatography-mass spectrometry. Prostaglandins 23:881-895.
10. 2. Proc Natl Acad Sci U S A 96:10501-10506.
11. Humes JL, Burger S, Galavage M, Kuehl FA Jr, Wightman PD, Dahlgren ME, Davies P, and Bonney RJ (1980) The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms. J Immunol 124:2110-2116.
12. Idzko M, Hammad H, van Nimwegen M, Kool M, Vos N, Hoogsteden HC, and Lambrecht BN (2007) Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 117:464-472.
13. Imai Y, Hayashi M, and Oh-ishi S (1991) Key role of complement activation and platelet-activating factor in exudate formation in zymosan-induced rat pleurisy. Jpn J Pharmacol 57:225-232.
14. Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao WH, Kume K, Fukuchi Y, Ikuta K, et al. (1998) Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187:1779-1788.
15. + Th2 cells into the airways in a mouse model of asthma. J Immunol 179:6193-6203.
16. 4 synthase. J Biol Chem 276:22608-22613.
17. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69:3-58.
18. Lachmann PJ and Hughes-Jones NC (1984) Initiation of complement activation. Springer Semin Immunopathol 7:143-162.
19. Lucas R, Villamon E, Paya M, Alves M, del Olmo E, Gozalbo D, and Gil ML (2004) LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice. FEMS Immunol Med Microbiol 40:239-242.
20. 2, arachidonic acid, and eicosanoid appearance in mouse zymosan peritonitis. J Immunol 144:2671-2677.
21. Morgan BP and Harris CL (2003) Complement therapeutics; history and current progress. Mol Immunol 40:159-170.
22. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678-682.
23. Narumiya S, Sugimoto Y, and Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
24. Noverr MC, Phare SM, Toews GB, Coffey MJ, and Huffnagle GB (2001) Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69:2957-2963.
25. Pillemer L, Blum L, Lepow IH, Ross OA, Todd EW, and Wardlaw AC (1954) The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120:279-285.
26. Rao TS, Currie JL, Shaffer AF, and Isakson PC (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269:917-925.
27. Rocha e Silva M (1978) A brief history of inflammation, in Handbook of Experimental Pharmacology (Vane JR and Ferreira SH eds) vol. 50/I, pp 6-25, Springer-Verlag, Berlin.
28. Romani L and Kaufmann SHE (1998) Immunity to fungi: editorial overview. Res Immunol 149:277-281.
29. Rouzer CA and Marnett LJ (2005) Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus. J Biol Chem 280:26690-26700.
30. Scott WA, Zrike JM, Hamill AL, Kempe J, and Cohn ZA (1980) Regulation of arachidonic acid metabolites in macrophages. J Exp Med 152:324-335.
31. Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, Nishimura T, Murata T, Matsuoka T, Ushikubi F, Hirose M, et al. (1998) Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 246:7-12.
32. 2 activation and cyclooxygenase 2 expression in macrophages by the β-glucan receptor. J Biol Chem 281:5506-5514.
33. 4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 307:1072-1078.
34. Tripp CS, Unanue ER, and Needleman P (1986) Monocyte migration explains the changes in macrophage arachidonate metabolism during the immune response. Proc Natl Acad Sci U S A 83:9655-9659.
35. Underhill DM (2003) Macrophage recognition of zymosan particles. J Endotoxin Res 9:176-180.
36. 3. Nature 395:281-284.
37. Utsunomiya I, Ito M, and Oh-ishi S (1998) Generation of inflammatory cytokines in zymosan-induced pleurisy in rats: TNF induces IL-6 and cytokine-induced neutrophil chemoattractant (CINC) in vivo. Cytokine 10:956-963.
38. Vane JR, Bakhle YS, and Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120.
39. Vinegar R, Truax JF, and Selph JL (1973) Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat. Proc Soc Exp Biol Med 143:711-714.
40. Yuhki K, Ueno A, Naraba H, Kojima F, Ushikubi F, Narumiya S, and Oh-ishi S (2004) Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy. J Pharmacol Exp Ther 311:1218-1224.